English Français
Register Sign In
Search Results

If you make changes to this saved search, you'll find the original and new searches in your account.

Your search filters:

chronic myelogenous leukemia

Narrow by:

Organization
Industry

  • Show Top 5

Subject

  • Show Top 5

Tag

  • Show More

  • Show Top 5

Date Published





Language

  • Show Top 5

Country

  • Show Top 5

State/Province

  • Show Top 5

Stock Market

  • Show Top 5

Continent

  • Show Top 5

Showing 1-1 of about 1 articles.

  • 1

Lixte Biotechnology Holdings, Inc.

LB-100 and LB-102, Lixte Biotechnology’s Protein Phosphatase 2A Inhibitors, Sensitize BCR-ABL Leukemia Stem Cells to Targeted Therapy with Tyrosine Kinase Inhibitors

about 69 days ago 

Showing 1-1 of about 1 articles.

  • 1
Newswire Distribution Network & Management
  • Home
  • Newsroom
  • RSS Feeds
  • Legal
  • Contact Us
About Us
GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
© 2018 GlobeNewswire, Inc. All Rights Reserved.